DNAシーケンス市場の2030年までの予測：製品、技術、用途、エンドユーザー、地域別の世界分析

Stratistics MRCによると、世界のDNAシーケンシング市場は2023年に125億米ドルを占め、予測期間中にCAGR 19.1％で成長し、2030年には425億米ドルに達する見込みです。

DNAシーケンシングは、異なるDNA鎖の配列を決定するために広範な並列化を使用する手順です。マイクロアレイや他の遺伝子解析技術に対するDNAシーケンシングの利点には、安価なコスト、高い精度とスピード、少量のサンプル投入でも信頼できる結果などがあります。DNAシーケンシングの用途には、バイオマーカーの同定、腫瘍学調査、個別化ヘルスケア、法医学などがあります。

National Human Genome Research Instituteによると、継続的な技術革新により、2021年8月には1ゲノムあたりのNGSコストは562米ドル、1メガベースあたりのNGSコストは0.006米ドルになります。

ゲノムシーケンス需要の高まり

ゲノムシークエンシングは、さまざまな分野に変革をもたらすため、DNAシークエンシング業界で需要が高まっています。さらに、遺伝子診断、オーダーメイド医療、がん研究においてゲノムシーケンスが必要であることから、臨床応用が増加しています。さらに、ゲノムシークエンシングの必要性は、ゲノミクスが病気の根底にあるメカニズムや潜在的な治療法に光を当て続けるにつれて高まると予想されます。このため、DNAシーケンサーの新製品開発と市場開拓が促進されるでしょう。

高コスト

DNAシーケンス技術の高コストは、主要な市場障害です。機器、消耗品、データ処理がこれらのコストに含まれるため、シーケンシングの取り組みが経済的に負担になることが多いです。さらに、シーケンスプログラムには、研究機関、臨床検査室、ヘルスケア施設から莫大な資金が必要であり、特にリソースが限られている環境では、高額な費用が最先端のシーケンス技術へのアクセスを制限し、普及を妨げる可能性があります。そのため、市場拡大の妨げとなっています。

DNAシーケンシングの技術的進歩

ゲノム研究および臨床応用は、DNAシーケンシングの技術開発により革命を遂げました。さらに、イルミナやオックスフォード・ナノポアなどの企業が提供する次世代シーケンシング（NGS）技術により、ハイスループットシーケンスが可能になりました。さらに、これらの開発により、大規模なゲノム研究がより手頃な価格で行えるようになり、データ収集もスピードアップしました。DNAシーケンスの精度は、1分子シーケンシングやロングリード技術によって向上し、複雑なゲノム領域の解析も容易になっています。さらに、研究者や臨床医が地方から臨床施設まで、さまざまな状況でシーケンス活動を実施できるようになり、ゲノミクスのアクセシビリティと効果が向上しました。したがって、これらの要因が市場拡大の大きな原動力となっています。

プライバシーとデータ解析に関連するリスク

DNAシーケンシング市場はプライバシーの問題によって阻害されてきました。遺伝子検査の利用が増えるにつれ、人々や組織は機密性の高い遺伝子データのセキュリティや悪用の可能性について懸念を表明するようになっています。さらに、このことが遺伝子研究に参加したりヘルスケア専門家と情報を共有したりすることをためらわせ、ゲノミクス研究や治療アプリケーションの開発を遅らせています。さらに、最新のシーケンス技術では膨大な量のデータが作成されるため、コンピューティングやデータ解析に大きな障害が生じ、効果的な解釈や活用が妨げられています。

COVID-19の影響

DNAシーケンス市場はCOVID-19の流行によってマイナスの影響を受けた。パンデミックは、サプライチェーンを混乱させ、研究室へのアクセスを制限し、ヘルスケア機関に財政的制約を生じさせることで、シーケンシングイニシアチブおよび非パンデミックプロジェクトに対する研究資金に影響を与えました。こうした課題にもかかわらず、パンデミックは感染症研究へのシーケンサー導入を加速させ、市場の拡大を徐々に抑制しました。

予測期間中、消耗品セグメントが最大となる見込み

消耗品セグメントは、DNA断片化、濃縮、アダプターライゲーション、増幅、品質管理など、ライブラリー構築の全フェーズに対応する試薬やキットが広く利用可能であることから、最大のシェアを占めると推定されます。さらに、サンプル調製や分析に使用される消耗品、フローセル、プライマー、バッファー、シーケンス試薬も含まれます。消耗品はDNAシーケンスの精度と有効性を保証するため、シーケンスワークフローに不可欠です。したがって、消耗品業界はメーカーに重要かつ安定した収入源を提供し、ゲノミクス研究、臨床診断、オーダーメイド医療の進歩に不可欠です。

次世代シーケンシングセグメントは予測期間中に最も高いCAGRが見込まれる

次世代シーケンシングセグメントは、予測期間中に有利な成長を遂げると予測されます。手ごろな価格で高品質のシーケンスデータを生成できることから、NGSはシーケンシング手法の主流となっています。さらに、NGSは従来のシーケンス技術よりも精度が高いことが示されており、がん検出やゲノム研究などの用途に適しています。さらに、次世代シーケンサー（NGS）システムと呼ばれる超並列シーケンサーは、短時間で大量のデータを生成することができます。したがって、その優れた精度と検出能力により、次世代シーケンサー技術はより大きな市場シェアを獲得すると予想されます。

最大のシェアを占める地域

アジア太平洋地域は、同地域の経済が積極的に参入しているため、予測期間中に最大の市場シェアを獲得しました。さらに、この地域の多くの国が大規模なゲノミクス構想や研究計画を開始しています。ヘルスケアへのゲノム応用を奨励する重要なイニシアティブの例としては、日本の「日本ゲノム医療プログラム」や中国の「精密医療イニシアティブ」などがあります。さらに、政府からの資金援助や大企業との提携も、この分野での技術革新を後押ししています。アジア太平洋地域の膨大な人口は、遺伝子検査とオーダーメイド医療のための大きな市場を生み出しています。その結果、この地域はゲノム研究とDNAシーケンサー分野の拡大の焦点となりつつあります。

CAGRが最も高い地域：

予測期間中、欧州のCAGRが最も高くなると予想されます。この地域は、活気ある科学コミュニティ、尊敬される研究機関、ゲノミクス研究への創造性と財政投資を促進する友好的な規制環境の恩恵を受けています。さらに、欧州諸国ではヘルスケアに多額の投資が行われた結果、個別化医療、遺伝子診断、薬理ゲノミクスにおけるゲノム応用の需要が高まっています。さらに、大規模なゲノミクスの取り組みは国際協力によって奨励され、この地域の競合を高めています。したがって、欧州の国民皆保険制度は、ゲノムデータを臨床診療に取り入れることを容易にし、市場の拡大を刺激しています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• 技術分析
• アプリケーション分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のDNAシーケンス市場：製品別

• 消耗品
• 楽器
• サービス

第6章 世界のDNAシーケンス市場：テクノロジー別

• 次世代シーケンス
• 第三世代DNAシーケンシング
• その他の技術

第7章 世界のDNAシーケンシング市場：アプリケーション別

• 腫瘍学
• 臨床調査
• 法医学とアグリゲノミクス
• ヒト白血球抗原（HLA）のタイピング
• リプロダクティブ・ヘルス
• その他の用途

第8章 世界のDNAシーケンス市場：最終用途別

• 学術調査
• 臨床調査
• バイオテクノロジーおよび製薬会社
• 病院とクリニック
• その他のエンドユーザー

第9章 世界のDNAシーケンシング市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• Agilent Technologies Inc.
• Pacific Biosciences of California Inc.
• Hamilton Thorne Biosciences
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Hoffmann-La Roche Ltd
• Illumina Inc.
• Merck KGaA
• Qiagen
• PerkinElmer Inc.
• Macrogen Inc.
• Myriad Genetics Inc.
• Eurofins Scientific

List of Tables

• Table 1 Global DNA Sequencing Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 4 Global DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 5 Global DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
• Table 6 Global DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
• Table 7 Global DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
• Table 8 Global DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
• Table 9 Global DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 10 Global DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
• Table 11 Global DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
• Table 12 Global DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
• Table 13 Global DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
• Table 14 Global DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
• Table 15 Global DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
• Table 16 Global DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 17 Global DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
• Table 18 Global DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
• Table 19 Global DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
• Table 20 Global DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
• Table 21 Global DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 22 Global DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 23 North America DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
• Table 24 North America DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
• Table 25 North America DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 26 North America DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 27 North America DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
• Table 28 North America DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
• Table 29 North America DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
• Table 30 North America DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
• Table 31 North America DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 32 North America DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
• Table 33 North America DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
• Table 34 North America DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
• Table 35 North America DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
• Table 36 North America DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
• Table 37 North America DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
• Table 38 North America DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 39 North America DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
• Table 40 North America DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
• Table 41 North America DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
• Table 42 North America DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
• Table 43 North America DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 44 North America DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 45 Europe DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
• Table 46 Europe DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
• Table 47 Europe DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 48 Europe DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 49 Europe DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
• Table 50 Europe DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
• Table 51 Europe DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
• Table 52 Europe DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
• Table 53 Europe DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 54 Europe DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
• Table 55 Europe DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
• Table 56 Europe DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
• Table 57 Europe DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
• Table 58 Europe DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
• Table 59 Europe DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
• Table 60 Europe DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 61 Europe DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
• Table 62 Europe DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
• Table 63 Europe DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
• Table 64 Europe DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
• Table 65 Europe DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 66 Europe DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 67 South America DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
• Table 68 South America DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
• Table 69 South America DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 70 South America DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 71 South America DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
• Table 72 South America DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
• Table 73 South America DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
• Table 74 South America DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
• Table 75 South America DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 76 South America DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
• Table 77 South America DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
• Table 78 South America DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
• Table 79 South America DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
• Table 80 South America DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
• Table 81 South America DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
• Table 82 South America DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 83 South America DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
• Table 84 South America DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
• Table 85 South America DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
• Table 86 South America DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
• Table 87 South America DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 88 South America DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 89 Middle East & Africa DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
• Table 90 Middle East & Africa DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
• Table 91 Middle East & Africa DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
• Table 92 Middle East & Africa DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
• Table 93 Middle East & Africa DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
• Table 94 Middle East & Africa DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
• Table 95 Middle East & Africa DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
• Table 96 Middle East & Africa DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
• Table 97 Middle East & Africa DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 98 Middle East & Africa DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
• Table 99 Middle East & Africa DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
• Table 100 Middle East & Africa DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
• Table 101 Middle East & Africa DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
• Table 102 Middle East & Africa DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
• Table 103 Middle East & Africa DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
• Table 104 Middle East & Africa DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 105 Middle East & Africa DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
• Table 106 Middle East & Africa DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
• Table 107 Middle East & Africa DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
• Table 108 Middle East & Africa DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
• Table 109 Middle East & Africa DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 110 Middle East & Africa DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global DNA Sequencing Market is accounted for $12.5 billion in 2023 and is expected to reach $42.5 billion by 2030 growing at a CAGR of 19.1% during the forecast period. DNA sequencing is a procedure that uses extensive parallelization to sequence different DNA strands. The advantages of DNA sequencing over microarray and other genetic analysis techniques include cheaper cost, higher accuracy and speed, and reliable results even with small sample input, applications for DNA sequencing include the identification of biomarkers, oncology research, individualized healthcare, forensics, and others.

According to National Human Genome Research Institute, due to continuous innovations, the cost of NGS per genome is USD 562, and the cost of NGS per megabase is USD 0.006 in August 2021.

Market Dynamics:

Driver:

Rising demand in genome sequencing

Genome sequencing is in greater demand in the DNA sequencing industry due to its transformational effects across a number of fields. Additionally, a rise in clinical applications is being caused by the necessity of genome sequencing in genetic diagnostics, customized medicine, and cancer research. Furthermore, the need for genome sequencing is anticipated to increase as genomics continues to shed light on the mechanisms underlying disease and potential treatments. Thus, this will encourage new product development and market expansion for DNA sequencing.

Restraint:

High cost

The high cost of DNA sequencing technologies is a key market obstacle. Equipment, consumables, and data processing are included in these costs, which frequently make sequencing efforts financially burdensome. Additionally, sequencing programs require huge amounts of cash from research institutions, clinical laboratories, and healthcare facilities, particularly in environments with limited resources, high expenses can restrict access to cutting-edge sequencing techniques and deter widespread adoption. Therefore, hampers the market expansion.

Opportunity:

Technological Advancements in DNA Sequencing

Genomic research and clinical applications have undergone a revolution due to technological developments in DNA sequencing. Additionally, high-throughput sequencing is made possible by next-generation sequencing (NGS) technologies from companies like Illumina and Oxford Nanopore. Moreover, because of the developments, large-scale genomic studies it has become more affordable, and data gathering has been speed up. The accuracy of DNA sequencing has increased because of single-molecule sequencing and long-read technologies, which also make it easier to analyze complex genomic areas. Furthermore, this has increased the accessibility and effect of genomics by enabling researchers and clinicians to conduct sequencing activities in a variety of contexts, from rural locations to clinical facilities. Therefore, these factors significantly have driven the market expansion.

Threat:

Risks associated with privacy and data analysis

The market for DNA sequencing has been hampered by privacy issues, as the use of genetic testing increases, people and organizations express concern about the security and potential abuse of highly sensitive genetic data. Additionally, this has made people hesitant to take part in genetic research and share information with healthcare professionals, which has slowed the development of genomics research and therapeutic applications. Furthermore, modern sequencing technologies create enormous amounts of data, which poses substantial computing and data analytic obstacles and hampers effective interpretation and utilization.

COVID-19 Impact

The market for DNA sequencing was negatively impacted by the COVID-19 epidemic. The pandemic impacted sequencing initiatives and research funding for non-pandemic projects by disrupting the supply chain, limiting laboratory access, and creating financial restrictions in healthcare institutions. Despite these challenges, the pandemic accelerated the adoption of sequencing for the research of infectious diseases, which gradually restrained market expansion.

The consumables segment is expected to be the largest during the forecast period

The consumables segment is estimated to hold the largest share, due to the widespread availability of reagents and kits for all library construction phases, including DNA fragmentation, enrichment, adapter ligation, amplification, and quality control. Additionally, this includes consumables used for sample preparation and analysis, flow cells, primers, buffers, and sequencing reagents. Consumables are essential to the sequencing workflow because they guarantee the precision and effectiveness of DNA sequencing. Therefore, the consumables industry provides manufacturers with a crucial and consistent source of income and is essential to the advancement of genomics research, clinical diagnostics, and customized medicine.

The next-generation sequencing segment is expected to have the highest CAGR during the forecast period

The next-generation sequencing segment is anticipated to have lucrative growth during the forecast period, due to its capacity to produce high-quality sequence data at affordable prices, NGS has become the predominant sequencing methodology. Furthermore, NGS has been shown to be more accurate than conventional sequencing techniques, making it appropriate for uses like cancer detection and genomics research. Moreover, massively parallel sequencers called next-generation sequencing (NGS) systems can produce a lot of data in a short amount of time. Therefore, due to its excellent accuracy and detection capacities, next-generation sequencing technology is anticipated to gain a greater market share.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to the active participation of the region's economies. Additionally, many nations in the region have started large-scale genomics initiatives and research plans. Examples of significant initiatives encouraging genomics applications in healthcare include Japan's "Japanese Genomic Medicine Program" and China's "Precision Medicine Initiative". Furthermore, governmental funding and partnerships with business titans are also encouraging innovation in the sector. The enormous population of the Asia-Pacific area creates a sizable market for genetic testing and tailored medicine. Thus, as a result, the area is gradually becoming a focus for genomics research and the expansion of the DNA sequencing sector.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period. The area benefits from a vibrant scientific community, esteemed research institutions, and a friendly regulatory environment that promotes creativity and financial investment in genomics research. Additionally, the demand for genomic applications in personalized medicine, genetic diagnostics, and pharmacogenomics has increased as a result of significant investments made in healthcare in European nations. Furthermore, large-scale genomics initiatives are encouraged by international cooperation, which raises the region's competitiveness. Therefore, the universal healthcare systems in Europe make it easier to incorporate genomic data into clinical practice, which stimulates market expansion.

Key players in the market:

Some of the key players in the DNA Sequencing Market include: Agilent Technologies Inc., Pacific Biosciences of California Inc., Hamilton Thorne Biosciences, Bio-Rad Laboratories Inc., Danaher Corporation, Hoffmann-La Roche Ltd, Illumina Inc., Merck KGaA, Qiagen, PerkinElmer Inc., Macrogen Inc., Myriad Genetics Inc. and Eurofins Scientific.

Key Developments:

In March 2023, llumina Inc. a global leader in DNA sequencing and array-based technologies, announced that its first product based on its novel Illumina Complete Long Read technology is now available to order.

In September 2022, Illumina, Inc. announced the launch of the NovaSeq™ X Series (NovaSeq X and NovaSeq X Plus), new production-scale sequencers that will push the limits of what is possible with genomic medicine, enabling faster, more powerful, and more sustainable sequencing.

In January 2019, NRGene and Macrogen Corp announced the launch of a joint sequencing-based genotyping service, ArrayMAGIC, at the Plant and Animal Genome (PAG) conference in San Diego.

Products Covered:

• Consumables
• Instruments
• Services

Technologies Covered:

• Next-Generation Sequencing
• Third Generation DNA Sequencing
• Other Technologies

Applications Covered:

• Oncology
• Clinical Investigation
• Forensics & Agrigenomics
• Human Leukocyte Antigen (HLA) Typing
• Reproductive Health
• Other Applications

End Users Covered:

• Academic Research
• Clinical Research
• Biotechnology & Pharmaceutical Companies
• Hospitals & Clinics
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 Application Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global DNA Sequencing Market, By Product

• 5.1 Introduction
• 5.2 Consumables
• 5.3 Instruments
• 5.4 Services

6 Global DNA Sequencing Market, By Technology

• 6.1 Introduction
• 6.2 Next-Generation Sequencing
• 6.3 Third Generation DNA Sequencing
• 6.4 Other Technologies

7 Global DNA Sequencing Market, By Application

• 7.1 Introduction
• 7.2 Oncology
• 7.3 Clinical Investigation
• 7.4 Forensics & Agrigenomics
• 7.5 Human Leukocyte Antigen (HLA) Typing
• 7.6 Reproductive Health
• 7.7 Other Applications

8 Global DNA Sequencing Market, By End Use

• 8.1 Introduction
• 8.2 Academic Research
• 8.3 Clinical Research
• 8.4 Biotechnology & Pharmaceutical Companies
• 8.5 Hospitals & Clinics
• 8.6 Other End Users

9 Global DNA Sequencing Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Agilent Technologies Inc.
• 11.2 Pacific Biosciences of California Inc.
• 11.3 Hamilton Thorne Biosciences
• 11.4 Bio-Rad Laboratories Inc.
• 11.5 Danaher Corporation
• 11.6 Hoffmann-La Roche Ltd
• 11.7 Illumina Inc.
• 11.8 Merck KGaA
• 11.9 Qiagen
• 11.10 PerkinElmer Inc.
• 11.11 Macrogen Inc.
• 11.12 Myriad Genetics Inc.
• 11.13 Eurofins Scientific